US20120136067A1 - Oil/water active ingredient emulsion containing uv filter - Google Patents
Oil/water active ingredient emulsion containing uv filter Download PDFInfo
- Publication number
- US20120136067A1 US20120136067A1 US13/119,036 US200913119036A US2012136067A1 US 20120136067 A1 US20120136067 A1 US 20120136067A1 US 200913119036 A US200913119036 A US 200913119036A US 2012136067 A1 US2012136067 A1 US 2012136067A1
- Authority
- US
- United States
- Prior art keywords
- emulsion
- ethylhexyl
- inci
- triazine
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 239000004480 active ingredient Substances 0.000 title description 7
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims abstract description 29
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 claims abstract description 26
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 claims abstract description 25
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 claims abstract description 25
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 229940069445 licorice extract Drugs 0.000 claims abstract description 16
- 229960000601 octocrylene Drugs 0.000 claims abstract description 13
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960005193 avobenzone Drugs 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- -1 glyceryl stearate SE Chemical compound 0.000 claims description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 239000002304 perfume Substances 0.000 claims description 8
- 239000012071 phase Substances 0.000 claims description 8
- 239000004904 UV filter Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 6
- 240000003183 Manihot esculenta Species 0.000 claims description 6
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 5
- 229940078812 myristyl myristate Drugs 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 4
- 229940049294 glyceryl stearate se Drugs 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 3
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 claims description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 3
- 229940114374 butylene glycol dicaprylate Drugs 0.000 claims description 3
- 229920006037 cross link polymer Polymers 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 claims description 2
- CENPSTJGQOQKKW-UHFFFAOYSA-N 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=CC=C(C=2N=C(N=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 CENPSTJGQOQKKW-UHFFFAOYSA-N 0.000 claims description 2
- VYUQQHWLPOUXOA-UHFFFAOYSA-N 2-(2,6-dimethyl-1h-pyridin-4-ylidene)propanedinitrile Chemical compound CC1=CC(=C(C#N)C#N)C=C(C)N1 VYUQQHWLPOUXOA-UHFFFAOYSA-N 0.000 claims description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 2
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004808 2-ethylhexylester Substances 0.000 claims description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 2
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 claims description 2
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical class CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 claims description 2
- NGJJZCPADSICRI-UHFFFAOYSA-N 4-[[4,6-bis(4-carboxyanilino)-1,3,5-triazin-2-yl]amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N=C(NC(=NC=1C=CC(=CC=1)C(O)=O)N1)NC1=NC1=CC=C(C(O)=O)C=C1 NGJJZCPADSICRI-UHFFFAOYSA-N 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- DTVQVQGCVNNOSX-UHFFFAOYSA-N bis(2-ethylhexyl) 2-[(4-methoxyphenyl)methylidene]propanedioate Chemical compound CCCCC(CC)COC(=O)C(C(=O)OCC(CC)CCCC)=CC1=CC=C(OC)C=C1 DTVQVQGCVNNOSX-UHFFFAOYSA-N 0.000 claims description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 229960004881 homosalate Drugs 0.000 claims description 2
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 claims description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 2
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229920002545 silicone oil Polymers 0.000 claims description 2
- 150000003460 sulfonic acids Chemical class 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 241000723346 Cinnamomum camphora Species 0.000 claims 1
- 229960000846 camphor Drugs 0.000 claims 1
- 229930008380 camphor Natural products 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 238000009472 formulation Methods 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 241000202807 Glycyrrhiza Species 0.000 description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 229940010454 licorice Drugs 0.000 description 9
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 229940032147 starch Drugs 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 3
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 3
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 229940031569 diisopropyl sebacate Drugs 0.000 description 3
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 3
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 3
- 239000001245 distarch phosphate Substances 0.000 description 3
- 235000013804 distarch phosphate Nutrition 0.000 description 3
- 229960000655 ensulizole Drugs 0.000 description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 3
- 229940084760 glycyrrhiza inflata root extract Drugs 0.000 description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 3
- 239000000347 magnesium hydroxide Substances 0.000 description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229940080313 sodium starch Drugs 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 3
- 229940094871 trimethoxycaprylylsilane Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- CWUADCSIKFLKRM-UHFFFAOYSA-N C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.N1=NN=CC=C1 Chemical compound C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.N1=NN=CC=C1 CWUADCSIKFLKRM-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 2
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- SBLKVIQSIHEQOF-OWOJBTEDSA-N (e)-octadec-9-enedioic acid Chemical compound OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O SBLKVIQSIHEQOF-OWOJBTEDSA-N 0.000 description 1
- PCXBTGYVVOXYPM-UHFFFAOYSA-N 1-(4-methylpentyl)cyclohex-3-en-1-ol Chemical compound CC(C)CCCC1(O)CCC=CC1 PCXBTGYVVOXYPM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- HKINASYXANIMHW-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO HKINASYXANIMHW-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- GMUDCCCPVSCMPS-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol;2-methoxyphenol;triazine Chemical compound C1=CN=NN=C1.COC1=CC=CC=C1O.CCCCCCOC1=C(O)C=CC(CC)=C1CC GMUDCCCPVSCMPS-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- OQHAOYHGURHBDD-UHFFFAOYSA-N butane-1,1-diol propane Chemical class CCC.CCCC(O)O OQHAOYHGURHBDD-UHFFFAOYSA-N 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 125000001303 disiloxanyl group Chemical group [H][Si]([*])([H])O[Si]([H])([H])[H] 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- LJZULWUXNKDPCG-UHFFFAOYSA-N nonane-1,2-diol Chemical compound CCCCCCCC(O)CO LJZULWUXNKDPCG-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N salicylic acid benzyl ester Natural products OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Definitions
- the present invention relates to a cosmetic O/W emulsion comprising
- the skin is the largest organ belonging to humans. It has a large number of vital functions to fulfill, for example the regulation of heat and the barrier function against drying out of the skin and of the entire organism, and as protective equipment against the penetration and absorption of external substances.
- This barrier function is effected through the epidermis, which as the outermost layer forms the actual protective covering against environmental conditions. With about one tenth of the total thickness, at the same time, it is the thinnest layer of the skin.
- the skin is exposed to a large number of physical, chemical and biological stresses. A large number of these stresses lead to temporary or permanent reddening of the skin for various reasons.
- the skin can fulfill its biological functions, it requires regular cleansing and care.
- active ingredients are as a rule added to cosmetic skin care products.
- the active ingredients employed in skin care include, for example, licorice extracts.
- the key active ingredient of licorice extract, in particular of Glycyrrhiza inflata, in this context is the compound licochalcone A, which has the following structure:
- Licorice extracts containing licochalcone A are employed in this context in particular to protect against skin irritations, such as reddenings.
- a disadvantage of the prior art of cosmetic formulations containing licorice extracts is, however, the fact that the extracts and in particular licochalcone A are not particularly storage-stable. If these formulations are stored for a relatively long period of time, and in particular at higher temperatures, degradation of the active ingredient(s) in the formulation occurs and the cosmetic slowly loses effectiveness. This loss in effectiveness occurs to a particularly high degree in O/W emulsions (oil-in-water emulsions).
- the object is achieved in particular by the use of a UV filter combination of
- the invention relates in this context in particular to the process for the preparation of an O/W emulsion containing licochalcone A and/or licorice extract, characterized in that
- the licorice extract which is preferred according to the invention originates from the plant Glycyrrhiza inflata.
- the extract is present in the form of an aqueous extract in which
- the cosmetic O/W emulsion according to the invention it is advantageous if the cosmetic O/W emulsion according to the invention, the use according to the invention or the process according to the invention is characterized in that the formulation or UV filter combination contains as a further constituent 2,4-bis- ⁇ [4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl ⁇ -6-(4-methoxyphenyl)-1,3,5-triazine (INCI: aniso triazine).
- the formulation or UV filter combination contains as a further constituent 2,4-bis- ⁇ [4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl ⁇ -6-(4-methoxyphenyl)-1,3,5-triazine (INCI: aniso triazine).
- Embodiments of the present invention which are advantageous according to the invention, characterized in that the formulation contains at least 2.1 wt.%, based on the total weight of the formulation, of 4-(tert-butyl)-4′-methoxydibenzoylmethane.
- 2,4-Bis- ⁇ [4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl ⁇ -6-(4-methoxyphenyl)-1,3,5-triazine is advantageously employed according to the invention in a concentration of 0.1 from to 5% by weight, based on the total weight of the formulation.
- the formulation contains one or more UV filters chosen from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3′-5,5′-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)-benzene and salts thereof; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2′-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-642-methyl-3-[1,3,3,3-tetramethyl-1-[
- the formulation according to the invention is free from p-methylbenzylidenecamphor.
- the formulation according to the invention contains ethanol.
- the formulation according to the invention can moreover advantageously contain one or more further compounds with an alcohol function, for example glycerol, 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol, propanols, propane- and butanediols.
- an alcohol function for example glycerol, 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol, propanols
- the formulation according to the invention contains one or more antioxidants.
- the formulation contains one or more compounds chosen from the group of the compounds tocopherol, tocopherol acetate, 2,6-di-tert-butyl-4-methylphenol.
- the formulation according to the invention can moreover contain one or more further active ingredients, for example alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and/or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, (3-alanine, tocopheryl acetate, dihydroxyacetone, 8-hexadecene-1,16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl)urea, niacinamide, vitamin A or its derivatives.
- active ingredients for example alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and/or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, (3-alanine, tocop
- the formulation contains one or more polymers.
- Embodiments which are preferred according to the invention are characterized in that the formulation contains one or more polymers chosen from the group of the compounds acrylate/C10-C30 alkyl acrylate cross polymer, acrylates, carbomers, tapioca starch, xanthan gum.
- the oily phase of the O/W emulsion contains one or more oil components chosen from the group of the compounds butylene glycol dicaprylate/dicaprate, myristyl myristate, octyldodecanol, C12-15 alkyl benzoate caprylic/capric triglyceride, diisopropyl sebacate, dicaprylyl ether, mineral oil, silicone oil.
- the formulation according to the invention contains one or more preservatives, in particular one or more parabens and/or phenoxyethanol.
- the O/W emulsion according to the invention can moreover contain further cosmetic active ingredients, auxiliary substances and additives, for example EDTA and perfume substances, such as limonene, linalool, benzyl benzoate, hydroxyisohexyl 3-cyclohexene, carboxaldehyde, hexyl cinnamal, benzyl salicylate, eugenol, butylphenyl methylpropional, alpha-isomethyl ionone, citronellol, coumarin, geraniol, cinnamyl alcohol, citral.
- EDTA EDTA and perfume substances
- perfume substances such as limonene, linalool, benzyl benzoate, hydroxyisohexyl 3-cyclohexene, carboxaldehyde, hexyl cinnamal, benzyl salicylate, eugenol, butylphenyl methylprop
- Sensorial additives can furthermore in the emulsion, such as distarch phosphate, sodium starch octenylsuccinate, aluminum starch octenylsuccinate, acrylonitrile/methacrylonitrile/methyl methacrylate copolymer+isopentane+magnesium hydroxide, tapioca starch, silica, nylon 6 polyamide 5, micronized talk.
- distarch phosphate sodium starch octenylsuccinate, aluminum starch octenylsuccinate, acrylonitrile/methacrylonitrile/methyl methacrylate copolymer+isopentane+magnesium hydroxide, tapioca starch, silica, nylon 6 polyamide 5, micronized talk.
- the hot aqueous phase advantageously has a temperature of from 50 to 95° C., preferably a temperature of from 75 to 90° C. and particularly preferably a temperature of about 85° C.
- a temperature of from 50 to 95° C. preferably a temperature of from 75 to 90° C. and particularly preferably a temperature of about 85° C.
- the term “about” in this context is intended solely to characterize the slight temperature variations typical of such processes.
- the heated oily phase advantageously has a temperature of from 50 to 95° C., preferably a temperature of from 75 to 90° C. and particularly preferably a temperature of about 85° C.
- the term “about” in this context is intended solely to characterize the slight temperature variations typical of such processes.
- Mixers from Becomix or Krieger are advantageously used according to the invention as homogenizers.
- the homogenization is advantageously carried out over a period of time of from 2 to 25 minutes.
- the stirring speed during the homogenization is advantageously from 500 to 2,000 rpm, a stirring speed of from 1,000 to 1,400 rpm being preferred according to the invention, and a stirring speed of 1,200 rpm (+ ⁇ 50 rpm) being particularly preferred according to the invention.
- the formulation is advantageously cooled to a temperature of from 25 to 40° C., a temperature of about 35° C. being preferred.
- a temperature of about 35° C. being preferred.
- the perfume substances and preservatives are preferably mixed with one another before the addition to the emulsion.
- the perfume substances and preservatives are preferably dissolved in ethanol before the addition to the emulsion.
- the formulations can serve for care of the skin, cosmetic protection from light or as a make-up product in decorative cosmetics.
- cosmetic compositions in the context of the present invention can be used, for example, as skin protection cream, day or night cream etc. It may be possible and advantageous to use the compositions according to the invention as a base for pharmaceutical formulations.
- the formulation according to the invention is used in particular for protection from ageing of the skin (in particular for protection from ageing of the skin of UV origin) and as a sunscreen composition.
- the formulation according to the invention advantageously has a pH of from 5 to 8. This can be established by conventional acids, bases and buffer systems.
- Recipe sample 1 contains a preparation without the stabilizers butyl methoxydibenzoyl methane and octocrylene. Recipe sample 2 additionally contains the two stabilizers.
- Sample 1 Sample 2 INCI name(s) m [%] m [%] Alcohol denat. 6.00 6.00 Sodium hydroxide 0.60 0.60 Cetearyl alcohol + PEG-40 castor oil + 2.00 2.00 sodium cetearyl sulfate Glyceryl stearate SE 0.80 0.80 Trisodium EDTA 1.00 1.00 Methylparaben 0.30 0.30 Phenoxyethanol 0.20 0.20 Bis-ethylhexyloxyphenol methoxyphenol triazine 3.50 3.50 Butyl methoxydibenzoyl methane 4.50 Diethylhexyl butamido triazone 1.00 1.00 Ethylhexyl methoxycinnamate + BHT 2.00 2.00 Octocrylene 4.50 Phenylbenzimidazole sulfonic acid 2.00 2.00 Glycerin 2.00 2.00 Butylene glycol dicaprylate/dicaprate 7.00 7.00 C12-15 alkyl benzoate 11.00 11.00 My
- the licorice content was determined by means of HPLC-DAD via an external calibration series.
- the licorice provided by the client was employed for the calibration, NART: 96146-90000-00, batch 17743901.
- the contents stated in the report are based on the reference substance employed for the calibration.
- the specimen sample 2 contains more licorice extract (licochalcone A) than the specimen sample 1.
- the addition of the stabilizers butyl methoxydibenzoyl methane and octocrylene leads to an increased heat and storage stability of the licorice extract (licochalcone A).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
A cosmetic oil/water emulsion comprising a) 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: Octocrylene), b) 4-(tert.-butyl)-4′-methoxydibenzoyl methane (INCI: Butylmethoxydibenzoyl methane), c) licorice extract or licochalcone A.
Description
- The present invention relates to a cosmetic O/W emulsion comprising
- a) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene),
- b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane),
- c) licorice extract or licochalcone A, and the preparation and use thereof
- The skin is the largest organ belonging to humans. It has a large number of vital functions to fulfill, for example the regulation of heat and the barrier function against drying out of the skin and of the entire organism, and as protective equipment against the penetration and absorption of external substances. This barrier function is effected through the epidermis, which as the outermost layer forms the actual protective covering against environmental conditions. With about one tenth of the total thickness, at the same time, it is the thinnest layer of the skin.
- The skin is exposed to a large number of physical, chemical and biological stresses. A large number of these stresses lead to temporary or permanent reddening of the skin for various reasons.
- So that the skin can fulfill its biological functions, it requires regular cleansing and care. In order to promote regeneration of the skin, to protect it from premature ageing or to avoid irritation, active ingredients are as a rule added to cosmetic skin care products.
- The active ingredients employed in skin care include, for example, licorice extracts. The key active ingredient of licorice extract, in particular of Glycyrrhiza inflata, in this context is the compound licochalcone A, which has the following structure:
- Licorice extracts containing licochalcone A are employed in this context in particular to protect against skin irritations, such as reddenings.
- A disadvantage of the prior art of cosmetic formulations containing licorice extracts (especially if these extracts contain licochalcone A) is, however, the fact that the extracts and in particular licochalcone A are not particularly storage-stable. If these formulations are stored for a relatively long period of time, and in particular at higher temperatures, degradation of the active ingredient(s) in the formulation occurs and the cosmetic slowly loses effectiveness. This loss in effectiveness occurs to a particularly high degree in O/W emulsions (oil-in-water emulsions).
- It was therefore the object of the present invention to eliminate the disadvantages of the prior art and to develop storage-stable or heat-stable cosmetic formulations which contain licorice extracts or licochalcone A.
- It was moreover the object of the present invention to develop a formulation which is easy and inexpensive to prepare.
- The object is achieved, surprisingly, by a cosmetic O/W emulsion comprising
- a) 2-ethylhexyl2-cyano-3,3-diphenylacrylate (INCI: octocrylene),
- b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane),
- c) licorice extract.
- The object is also achieved, surprisingly, by a cosmetic O/W emulsion comprising
- a) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene),
- b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane),
- c) licochalcone A.
- Surprisingly, the object is achieved in particular by the use of a UV filter combination of
- a) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene),
- b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane) to increase the storage stability of licochalcone A or licorice extracts in cosmetic O/W emulsions.
- The invention relates in this context in particular to the process for the preparation of an O/W emulsion containing licochalcone A and/or licorice extract, characterized in that
- a) first the hot aqueous phase is provided,
- b) the heated oily phase containing 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, 4-(tert-butyl)-4′-methoxydibenzoylmethane and optionally further oil-soluble UV filters, such as 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl }-6-(4-methoxyphenyl)-1,3,5-triazine, is added to the hot aqueous phase,
- c) the two phases are subsequently homogenized to give an O/W emulsion,
- d) the formulation is cooled,
- e) the licorice extract dissolved in ethanol or the licochalcone A dissolved in ethanol is stirred into the emulsion, and the perfume substances and preservatives are subsequently added, and a cosmetic O/W emulsion prepared by this process.
- The person skilled in the art indeed knows per se cosmetic formulations with licorice extracts, and in particular with licochalcone A. The German laid-open specifications DE 102 24 387.5, DE 103 52 368.5, DE 103 52 367.7, DE 103 56 723.2, DE 103 56 175.7, DE 103 42 212.9, DE 103 52 369.3, DE 103 56 187.0, DE 103 57 451.4, DE 103 57 452.2, DE 103 56 164.1, DE 103 56 870.0, DE 103 56 869.7 and DE 103 56 866.2 thus describe formulations containing licochalcone A. However, these specifications have not been able to indicate the path to the present invention, since in the recipes disclosed either one of the UV filters required for the invention is missing, or the compositions are present in another base (in particular W/O emulsion).
- The licorice extract which is preferred according to the invention originates from the plant Glycyrrhiza inflata.
- According to the invention, it is furthermore advantageous if the extract is present in the form of an aqueous extract in which
-
- licochalcone A
- water
- optionally one or more polyols
are present.
- According to the invention, it is advantageous if the cosmetic O/W emulsion according to the invention, the use according to the invention or the process according to the invention is characterized in that the formulation or UV filter combination contains as a further constituent 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: aniso triazine).
- Where formulations according to the invention or advantageous embodiments etc. are referred to in the context of the present description, this also always relates to the use according to the invention and the preparation process according to the invention or the process product according to the invention.
- Embodiments of the present invention which are advantageous according to the invention, characterized in that the formulation contains at least 2.1 wt.%, based on the total weight of the formulation, of 4-(tert-butyl)-4′-methoxydibenzoylmethane.
- It is generally preferable according to the invention to employ the constituents according to the invention in the following concentrations:
- a) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene) in a concentration of from 0.1 to 12% by weight, based on the total weight of the formulation.
- b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane) in a concentration of from 0.1 to 8% by weight, based on the total weight of the formulation.
- c) licorice extract in a concentration of from 0.001 to 0.05% by weight, based on the total weight of the formulation.
- c) licochalcone A in a concentration of from 0.0001 to 0.01% by weight, based on the total weight of the formulation.
- 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine is advantageously employed according to the invention in a concentration of 0.1 from to 5% by weight, based on the total weight of the formulation.
- It is advantageous according to the invention if glyceryl stearate citrate, glyceryl stearate SE, stearic acid, polyglyceryl-3 methylglucose distearate, PEG-40 stearate, PEG-100 stearate, potassium cetyl phosphate and/or a mixture of cetearyl alcohol+PEG-40 hydrogenated castor oil+sodium cetearyl sulfate+glyceryl stearate, sodium stearoyl glutamate, sucrose polystearate+hydrogenated polyisobutene polyglyceryl-3 methylglucose distearate triceteareth-4 phosphate is employed as the O/W emulsifier.
- Advantageous embodiments according to the invention are also characterized in that the formulation contains one or more UV filters chosen from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3′-5,5′-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)-benzene and salts thereof; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2′-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-642-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidenecamphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(dimethylamino)benzoic acid amyl ester; 4-methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; 4-methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4′-methylbenzophenone; 2,2′-dihydroxy-4-methoxybenzophenone; 2-(4′-diethylamino-2′-hydoxybenzoyl)-benzoic acid hexyl ester, homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzal malonate; 3-(4-(2,2-bis ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxane/dimethylsiloxane copolymer; dioctylbutylamidotriazone (INCI: diethylhexyl-butamido triazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine with the (CAS no. 288254-16-0); 4,4′,4″-(1,3,5-triazine-2,4,6-triyltriimino)-tris-benzoic acid tris(2-ethylhexyl ester) (also: 2,4,6-tris-[anilino-(p-carbo-2′-ethyl-1′-hexyloxy)]-1,3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis-(4′-dineopentylaminobenzalmalonate)-6-(4″-butylaminobenzoate)-s-triazine, titanium dioxide, zinc oxide, trisbiphenyl-triazine 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N-(ethyloxysulfate ester salt) mono-sodium salt.
- It is advantageous according to the invention if the formulation according to the invention is free from p-methylbenzylidenecamphor.
- It is preferable according to the invention if the formulation according to the invention contains ethanol. The formulation according to the invention can moreover advantageously contain one or more further compounds with an alcohol function, for example glycerol, 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol, propanols, propane- and butanediols.
- It is advantageous according to the invention if the formulation according to the invention contains one or more antioxidants.
- It is preferable according to the invention if the formulation contains one or more compounds chosen from the group of the compounds tocopherol, tocopherol acetate, 2,6-di-tert-butyl-4-methylphenol.
- The formulation according to the invention can moreover contain one or more further active ingredients, for example alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and/or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, (3-alanine, tocopheryl acetate, dihydroxyacetone, 8-hexadecene-1,16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl)urea, niacinamide, vitamin A or its derivatives.
- It is advantageous according to the invention if the formulation contains one or more polymers. Embodiments which are preferred according to the invention are characterized in that the formulation contains one or more polymers chosen from the group of the compounds acrylate/C10-C30 alkyl acrylate cross polymer, acrylates, carbomers, tapioca starch, xanthan gum.
- It is advantageous in the context of the present invention if the oily phase of the O/W emulsion contains one or more oil components chosen from the group of the compounds butylene glycol dicaprylate/dicaprate, myristyl myristate, octyldodecanol, C12-15 alkyl benzoate caprylic/capric triglyceride, diisopropyl sebacate, dicaprylyl ether, mineral oil, silicone oil.
- It is advantageous according to the invention if the formulation according to the invention contains one or more preservatives, in particular one or more parabens and/or phenoxyethanol.
- The O/W emulsion according to the invention can moreover contain further cosmetic active ingredients, auxiliary substances and additives, for example EDTA and perfume substances, such as limonene, linalool, benzyl benzoate, hydroxyisohexyl 3-cyclohexene, carboxaldehyde, hexyl cinnamal, benzyl salicylate, eugenol, butylphenyl methylpropional, alpha-isomethyl ionone, citronellol, coumarin, geraniol, cinnamyl alcohol, citral.
- Sensorial additives can furthermore in the emulsion, such as distarch phosphate, sodium starch octenylsuccinate, aluminum starch octenylsuccinate, acrylonitrile/methacrylonitrile/methyl methacrylate copolymer+isopentane+magnesium hydroxide, tapioca starch, silica, nylon 6 polyamide 5, micronized talk.
- The preparation process according to the invention and the product prepared by the preparation process are characterized according to the invention as advantageous according to the invention by the following details:
- It is thus advantageous according to the invention if the emulsifier(s) has/have been added to the oily phase before this is added to the aqueous phase.
- According to the invention, the hot aqueous phase advantageously has a temperature of from 50 to 95° C., preferably a temperature of from 75 to 90° C. and particularly preferably a temperature of about 85° C. The term “about” in this context is intended solely to characterize the slight temperature variations typical of such processes.
- According to the invention, the heated oily phase advantageously has a temperature of from 50 to 95° C., preferably a temperature of from 75 to 90° C. and particularly preferably a temperature of about 85° C. The term “about” in this context is intended solely to characterize the slight temperature variations typical of such processes.
- Mixers from Becomix or Krieger are advantageously used according to the invention as homogenizers.
- According to the invention, the homogenization is advantageously carried out over a period of time of from 2 to 25 minutes.
- According to the invention, the stirring speed during the homogenization is advantageously from 500 to 2,000 rpm, a stirring speed of from 1,000 to 1,400 rpm being preferred according to the invention, and a stirring speed of 1,200 rpm (+−50 rpm) being particularly preferred according to the invention.
- In process step d), according to the invention the formulation is advantageously cooled to a temperature of from 25 to 40° C., a temperature of about 35° C. being preferred. The term “about” in this context is intended solely to characterize the slight temperature variations typical of such processes.
- The perfume substances and preservatives are preferably mixed with one another before the addition to the emulsion.
- The perfume substances and preservatives are preferably dissolved in ethanol before the addition to the emulsion.
- The addition of the perfume substances and preservatives is advantageously carried out according to the invention at a temperature of below 30° C.
- Advantageously, in the context of the present invention the formulations can serve for care of the skin, cosmetic protection from light or as a make-up product in decorative cosmetics.
- According to their make-up, cosmetic compositions in the context of the present invention can be used, for example, as skin protection cream, day or night cream etc. It may be possible and advantageous to use the compositions according to the invention as a base for pharmaceutical formulations.
- According to the invention, the formulation according to the invention is used in particular for protection from ageing of the skin (in particular for protection from ageing of the skin of UV origin) and as a sunscreen composition.
- According to the invention, the formulation according to the invention advantageously has a pH of from 5 to 8. This can be established by conventional acids, bases and buffer systems.
- Comparison Experiments
- It was possible to demonstrate the inventive effect with the following comparison experiments:
- The following recipes were prepared and the content of licorice extract (containing licochalcone A) was determined before and after storage for 4 weeks in an incubating cabinet at 40° C.
- Recipe sample 1 contains a preparation without the stabilizers butyl methoxydibenzoyl methane and octocrylene. Recipe sample 2 additionally contains the two stabilizers.
-
Sample 1 Sample 2 INCI name(s) m [%] m [%] Alcohol denat. 6.00 6.00 Sodium hydroxide 0.60 0.60 Cetearyl alcohol + PEG-40 castor oil + 2.00 2.00 sodium cetearyl sulfate Glyceryl stearate SE 0.80 0.80 Trisodium EDTA 1.00 1.00 Methylparaben 0.30 0.30 Phenoxyethanol 0.20 0.20 Bis-ethylhexyloxyphenol methoxyphenol triazine 3.50 3.50 Butyl methoxydibenzoyl methane 4.50 Diethylhexyl butamido triazone 1.00 1.00 Ethylhexyl methoxycinnamate + BHT 2.00 2.00 Octocrylene 4.50 Phenylbenzimidazole sulfonic acid 2.00 2.00 Glycerin 2.00 2.00 Butylene glycol dicaprylate/dicaprate 7.00 7.00 C12-15 alkyl benzoate 11.00 11.00 Myristyl myristate 2.00 2.00 Octyldodecanol 5.50 5.50 Glycyrrhiza inflata root extract (licochalcone A) 0.025 0.025 Titanium dioxide + trimethoxycaprylylsilane 4.00 4.00 Acrylates/C10-30 alkyl acrylate cross polymer 0.05 0.05 Cetyl alcohol 2.50 2.50 Tapioca starch 1.00 1.00 Xanthan gum 0.80 0.80 Tocopheryl acetate 0.50 0.50 Water to 100.000 to 100.000 - Experimental Design:
- Determination of the licorice content (licochalcone A) of the test sample after 4 weeks storage stability at 40° C. incubating cabinet storage.
- Method Employed:
- The licorice content was determined by means of HPLC-DAD via an external calibration series. The licorice provided by the client was employed for the calibration, NART: 96146-90000-00, batch 17743901. The contents stated in the report are based on the reference substance employed for the calibration.
- Results:
-
Content in % Sample designation actual theoretical Sample 1 <0.005 0.025 Sample 2 0.018 0.025 - Conclusion:
- The specimen sample 2 contains more licorice extract (licochalcone A) than the specimen sample 1. The addition of the stabilizers butyl methoxydibenzoyl methane and octocrylene leads to an increased heat and storage stability of the licorice extract (licochalcone A).
- The following examples are intended to illustrate the present invention without limiting it. Unless stated otherwise, all the amounts data, contents and percentage contents are based on the weight and the total amount or on the total weight of the formulations.
-
1 2 3 4 INCI name(s) m [%] m [%] m [%] m [%] Acrylonitrile/methacrylonitrile/methyl 0.30 0.10 methacrylate copolymer + isopentane + magnesium hydroxide Tapioca starch 0.50 1.00 Sodium starch octenylsuccinate 0.30 0.80 Polyamide 5 0.50 Distarch phosphate 0.80 Aluminum starch octenylsuccinate 0.50 Alcohol denat. 8.00 7.00 8.00 5.00 Dicaprylyl ether 1.00 2.00 Caprylic/capric triglyceride 2.00 1.00 Diisopropyl sebacate 4.00 5.00 C12-15 alkyl benzoate 8.00 2.00 6.50 Cetearyl alcohol + PEG-40 castor oil + 2.00 1.00 2.50 1.00 sodium cetearyl sulfate Cetyl alcohol 1.00 2.20 1.50 Ethylhexyl salicylate 4.50 2.00 1.00 Bis-ethylhexyloxyphenol methoxyphenyl 2.30 1.00 2.50 1.50 triazine Butyl methoxydibenzoyl methane 4.50 5.00 2.00 4.50 Phenylbenzimidazole sulfonic acid 2.50 1.00 4.00 2.00 Diethylamino hydroxybenzoyl hexyl 2.00 4.00 benzoate Octocrylene 5.00 9.00 7.00 4.50 Diethylhexyl butamido triazone 1.00 1.50 Glycerin 5.00 2.00 0.90 8.00 Glyceryl stearate SE 0.50 1.00 0.50 0.65 Glycyrrhiza inflata root extract 0.10 0.01 0.02 0.03 Methylparaben 0.30 0.20 0.20 Myristyl myristate 1.00 1.50 3.00 1.50 Octyldodecanol 5.50 4.00 2.00 Phenoxyethanol 0.20 0.10 0.20 0.20 Titanium dioxide + 2.00 3.00 1.50 5.00 trimethoxycaprylylsilane Tocopheryl acetate 0.50 0.50 0.10 0.50 Perfume q.s. q.s. q.s. q.s. Sodium hydroxide q.s. q.s. q.s. q.s. Trisodium EDTA q.s q.s. q.s. q.s. Xanthan gum 0.40 0.40 0.40 0.40 Water to 100.00 to 100.00 to 100.00 to 100.00 5 6 7 8 9 INCI name(s) m [%] m [%] m [%] m [%] m [%] Acrylonitrile/methacrylonitrile/methyl 0.30 0.10 methacrylate copolymer + isopentane + magnesium hydroxide Tapioca starch 0.50 1.00 1.00 Sodium starch octenylsuccinate 0.30 0.80 Polyamide 5 0.50 0.50 Distarch phosphate 0.80 Aluminum starch octenylsuccinate 0.50 Potassium cetyl phosphate 2.00 Sodium stearoyl glutamate 2.50 Sucrose polystearate + hydrogenated 0.50 polyisobutene Polyglyceryl-3 methylglucose distearate 5.00 Triceteareth-4 phosphate 2.00 Stearic acid 2.50 Alcohol denat. 8.00 7.00 8.00 5.00 5.00 Dicaprylyl ether 1.00 2.00 2.00 Caprylic/capric triglyceride 2.00 1.00 1.00 Diisopropyl sebacate 4.00 5.00 C12-15 alkyl benzoate 8.00 2.00 6.50 6.50 Cetyl alcohol 1.00 2.20 1.50 1.50 Ethylhexyl salicylate 4.50 2.00 1.00 1.00 Bis-ethylhexyloxyphenol methoxyphenyl 2.30 1.00 2.50 1.50 1.50 triazine Butyl methoxydibenzoyl methane 4.50 5.00 2.00 4.50 4.50 Phenylbenzimidazole sulfonic acid 2.50 1.00 4.00 2.00 2.00 Diethylamino hydroxybenzoyl hexyl 2.00 4.00 benzoate Octocrylene 5.00 9.00 7.00 4.50 4.50 Diethylhexyl butamido triazone 1.00 1.50 1.50 Glycerin 5.00 2.00 0.90 8.00 8.00 Glycyrrhiza inflata root extract 0.10 0.01 0.02 0.03 0.03 Methylparaben 0.30 0.20 0.20 Myristyl myristate 1.00 1.50 3.00 1.50 1.50 Octyldodecanol 5.50 4.00 2.00 Phenoxyethanol 0.20 0.10 0.20 0.20 0.20 Titanium dioxide + 2.00 3.00 1.50 5.00 5.00 trimethoxycaprylylsilane Tocopheryl acetate 0.50 0.50 0.10 0.50 0.50 Perfume q.s. q.s. q.s. q.s. q.s. Sodium hydroxide q.s. q.s. q.s. q.s. q.s. Trisodium EDTA q.s. q.s. q.s. q.s. q.s. Xanthan gum 0.40 0.40 0.40 0.40 0.40 Water to to to to to 100.00 100.00 100.00 100.00 100.00
Claims (21)
1.-15. (canceled)
16. A cosmetic O/W emulsion, wherein the emulsion comprises
(a) 2-ethyl-hexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene),
(b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (NCI: butyl methoxydibenzoyl methane), and
(c) at least one of a licorice extract and licochalcone A.
17. The emulsion of claim 16 , wherein the emulsion further comprises (d) 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: aniso triazine).
18. The emulsion of claim 16 , wherein the emulsion comprises, based on a total weight of the emulsion, from 0.1% to 12% by weight of (a), from 0.1% to 8% by weight of (b), and at least one of from 0.0001% to 0.05% by weight of licorice extract and from 0.0001% to 0.01% by weight of licochalcone A.
19. The emulsion of claim 16 , wherein the emulsion comprises at least 2.1% by weight of (b), based on a total weight of the emulsion.
20. The emulsion of claim 17 , wherein the emulsion comprises from 0.1% to 5% by weight of (d), based on a total weight of the emulsion.
21. The emulsion of claim 16 , wherein the emulsion further comprises one or more of glyceryl stearate citrate, glyceryl stearate SE, stearic acid, polyglyceryl-3 methylglucose distearate, PEG-40 stearate, PEG-100 stearate, potassium cetyl phosphate, and a mixture of cetearyl alcohol+PEG-40 hydrogenated castor oil+sodium cetearyl sulfate+glyceryl stearate as an O/W emulsifier.
22. The emulsion of claim 16 , wherein the emulsion further comprises one or more UV filters selected from phenylene-1,4-bis-(2-benzimidazyl)-3,3′-5,5′-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)-benzene and salts thereof; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2′-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene)camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(dimethylamino)benzoic acid amyl ester; 4-methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; 4-methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4′-methylbenzophenone; 2,2′-dihydroxy-4-methoxybenzophenone; 2-(4′-diethylamino-2′-hydoxybenzoyl)-benzoic acid hexyl ester, homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzal malonate; 3-(4-(2,2-bis ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxane/dimethylsiloxane copolymer; dioctylbutyl-amidotriazone (INCI: diethylhexyl-butamido triazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine; 4,4′,4″-(1,3,5-triazine-2,4,6-triyltriimino)-tris-benzoic acid tris(2-ethylhexyl ester) (INCI: ethylhexyl triazone); 2,4-bis-(4′-di-neopentylaminobenzalmalonate)-6-(4″-butylaminobenzoate)-s-triazine, titanium dioxide; zinc oxide; trisbiphenyl-triazine 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N-(ethyloxysulfate ester salt) mono-sodium salt.
23. The emulsion of claim 16 , wherein the emulsion further comprises ethanol.
24. The emulsion of claim 16 , wherein the emulsion further comprises one or more antioxidants.
25. The emulsion of claim 24 , wherein the emulsion further comprises one or more of tocopherol, tocopherol acetate, and 2,6-di-tert-butyl-4-methylphenol.
26. The emulsion of claim 16 , wherein the emulsion further comprises one or more polymers.
27. The emulsion of claim 26 , wherein the emulsion further comprises one or more polymers selected from acrylate/C10-C30 alkyl acrylate crosspolymers, polyacrylates, tapioca starch, and xanthan gum.
28. The emulsion of claim 16 , wherein the emulsion further comprises one or more oil components selected from butylene glycol dicaprylate/dicaprate, myristyl myristate, octyldodecanol, mineral oil, and silicone oil.
29. The emulsion of claim 16 , wherein the emulsion comprises a licorice extract.
30. The emulsion of claim 16 , wherein the emulsion comprises licochalcone A.
31. A process for the preparation of a cosmetic O/W emulsion, wherein the process comprises
(i) adding a heated oil phase comprising 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, 4-(tert-butyl)-4′-methoxydibenzoylmethane and, optionally, one or more further oil-soluble UV filters to a hot aqueous phase,
(ii) homogenizing the oil and water phases to obtain an O/W emulsion,
(iii) cooling the emulsion, and
(iv) adding at least one of licorice extract dissolved in ethanol and licochalcone A dissolved in ethanol to the cooled emulsion with stirring.
32. The process of claim 31 , wherein one or more perfume substances and one or more preservatives are further added in (iv).
33. The process of claim 31 , wherein the heated oil phase of (i) further comprises 2,4-bis-[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine.
34. The emulsion obtained by the process of claim 31 .
35. A method of increasing the storage stability of a cosmetic O/W emulsion that comprises one or both of a licorice extract and licochalcone A, wherein the method comprises including in the emulsion a combination of (a) 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: octocrylene) and (b) 4-(tert-butyl)-4′-methoxydibenzoylmethane (INCI: butyl methoxydibenzoyl methane) in an amount that is sufficient to increase the storage stability of the emulsion.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008048328A DE102008048328A1 (en) | 2008-09-16 | 2008-09-16 | UV filter-containing O / W active ingredient emulsion |
| DE102008048328.1 | 2008-09-16 | ||
| PCT/EP2009/006608 WO2010031522A1 (en) | 2008-09-16 | 2009-09-11 | Oil/water active ingredient emulsion containing uv filter |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2009/006608 A-371-Of-International WO2010031522A1 (en) | 2008-09-16 | 2009-09-11 | Oil/water active ingredient emulsion containing uv filter |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/359,841 Division US10603256B2 (en) | 2008-09-16 | 2016-11-23 | Oil/water active ingredient emulsion containing UV filter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20120136067A1 true US20120136067A1 (en) | 2012-05-31 |
Family
ID=41491453
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/119,036 Abandoned US20120136067A1 (en) | 2008-09-16 | 2009-09-11 | Oil/water active ingredient emulsion containing uv filter |
| US15/359,841 Expired - Fee Related US10603256B2 (en) | 2008-09-16 | 2016-11-23 | Oil/water active ingredient emulsion containing UV filter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/359,841 Expired - Fee Related US10603256B2 (en) | 2008-09-16 | 2016-11-23 | Oil/water active ingredient emulsion containing UV filter |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20120136067A1 (en) |
| EP (2) | EP2337545B1 (en) |
| DE (1) | DE102008048328A1 (en) |
| ES (2) | ES2392386T3 (en) |
| WO (1) | WO2010031522A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170038262A (en) * | 2015-09-30 | 2017-04-07 | (주)아모레퍼시픽 | Oil-in-water type emulsion composition |
| WO2020025257A1 (en) | 2018-07-30 | 2020-02-06 | Unilever N.V. | Compositions comprising active botanical ingredients |
| JP2023500806A (en) * | 2019-11-05 | 2023-01-11 | ディーエスエム アイピー アセッツ ビー.ブイ. | Non-sticky sunscreen composition |
| CN116327704A (en) * | 2023-04-03 | 2023-06-27 | 浙江固瓴生物科技有限公司 | A preparation method and application of nano liquid crystal carrier containing licochalcone A |
| CN120732759A (en) * | 2025-07-31 | 2025-10-03 | 广东肤韵生物科技研究有限公司 | High-power sun-screening composition with light and thin skin feel and preparation method and application thereof |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011079256A1 (en) * | 2011-07-15 | 2013-01-17 | Henkel Ag & Co. Kgaa | Sunscreen compositions with improved antioxidant potential to protect the skin from IR radiation |
| DE102014206224A1 (en) * | 2014-04-01 | 2015-10-01 | Beiersdorf Ag | Cosmetic preparation with UV protection |
| DE102014206214A1 (en) * | 2014-04-01 | 2015-10-01 | Beiersdorf Ag | Method of protecting the skin from UV radiation |
| EP3037083A1 (en) * | 2014-12-22 | 2016-06-29 | Spirig Pharma AG | Emulsifier-free cosmetic sunscreen composition |
| CN110015691B (en) * | 2019-05-27 | 2021-10-01 | 山东师范大学 | A kind of method for preparing nano-scale barium molybdate particles |
| CN115151311A (en) * | 2020-04-08 | 2022-10-04 | 拜尔斯道夫股份有限公司 | Anti-fouling composition |
| DE102020210312A1 (en) * | 2020-08-13 | 2022-02-17 | Beiersdorf Aktiengesellschaft | Cosmetic ethanol-in-oil emulsion |
| CN113827495B (en) * | 2021-11-17 | 2023-10-20 | 青海倍力甘草科技发展有限责任公司 | Sun-screening agent and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562353B1 (en) * | 1998-05-12 | 2003-05-13 | Societe L'oreal S.A. | Desquamation/epidermal renewal of the skin and/or combating skin aging |
| US20100104523A1 (en) * | 2007-01-25 | 2010-04-29 | Ciba Corporation | Stabilization of uv-sensitive active ingredients |
| US20100166687A1 (en) * | 2007-03-01 | 2010-07-01 | Coty Prestige Lancaster Group Gmbh | Cosmetic light protection agent |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429468C2 (en) * | 1994-08-19 | 1998-07-09 | Beiersdorf Ag | Use of hydrophobized anorganic pigments to maintain the skin's urocanic acid status during bathing |
| KR0154366B1 (en) * | 1995-07-10 | 1998-11-16 | 성재갑 | Liquid crystal gel for stabilized oil soluble extracts of glyoyrrhizae radix and cosmetic compositions containing the same |
| DE10208265A1 (en) * | 2002-02-26 | 2003-09-11 | Beiersdorf Ag | Continuous production of cosmetic and/or dermatological compositions, containing temperature-sensitive components, comprises emulsification, addition of sensitive components and then homogenization |
| US6869598B2 (en) * | 2002-03-22 | 2005-03-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of sunscreens in cosmetic compositions |
| DE10224387A1 (en) | 2002-06-01 | 2003-12-11 | Beiersdorf Ag | Cosmetic or dermatological preparations with a prepared extract from Radix Glycyrrhizae inflatae |
| DE10238449A1 (en) * | 2002-08-22 | 2004-03-04 | Beiersdorf Ag | Cosmetic and / or dermatological preparation |
| CN1520811A (en) | 2003-02-14 | 2004-08-18 | 丸善制药株式会社 | External composition containing oil-soluble licorice extract and method for stabilizing the same |
| DE10342212A1 (en) | 2003-09-12 | 2005-04-07 | Beiersdorf Ag | Use of Licocalchon A or Licocalchon A containing extract from Radix Glycyrrhizae inflatae against skin aging |
| DE10352368A1 (en) | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Treatment of insect bites using licochalcone A or extracts of Radix Glycyrrhizae inflatae, provides long-lasting suppression of redness, itching and swelling |
| DE10352369A1 (en) | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Use of Licocalchon A or Licocalchon A containing Extract of Radix Glycyrrhizae inflatae against postinflammatory hyperpigmentation |
| DE10352367A1 (en) | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Treatment of rosacea using licochalcone A or extracts of Radix Glycyrrhizae inflatae, provides long-lasting suppression of redness and inhibits further outbreaks |
| DE10356723A1 (en) | 2003-12-02 | 2005-06-30 | Beiersdorf Ag | Cosmetic deodorant, selectively reducing the numbers of odor-producing skin bacteria, containing licochalcone A, optionally in the form of Glycyrrhizae inflatae root extract |
| DE10356187A1 (en) | 2003-12-02 | 2005-07-21 | Beiersdorf Ag | Active substance combinations of phytosterols and / or cholesterol and licochalcone A or an aqueous extract of Radix Glycyrrhizae inflatae, containing licochalcone A. |
| DE10356164A1 (en) | 2003-12-02 | 2005-08-04 | Beiersdorf Ag | Active ingredient combinations of licochalcone A or an extract of Radix Clycyrrhizae inflatae, containing licochalcone A, phenoxyethanol and, if desired, glycerol |
| DE10357451A1 (en) | 2003-12-03 | 2005-07-07 | Beiersdorf Ag | Active substance combinations of 2,3-dibenzylbutyrolactones and licochalcone A or an aqueous extract of Radix Glycyrrhizae inflatae, containing licochalcone A. |
| DE10356864A1 (en) * | 2003-12-03 | 2005-07-07 | Beiersdorf Ag | Cosmetic and dermatological preparations containing licochalcone A and soybean germ extracts |
| DE10356870A1 (en) | 2003-12-03 | 2005-07-07 | Beiersdorf Ag | Hair styling composition, useful particularly for treating scalps damaged by surfactants, contains a setting polymer and licochalcone A, optionally as a licorice extract |
| DE10356866A1 (en) | 2003-12-03 | 2005-07-21 | Beiersdorf Ag | Hair and / or scalp care products with licochalcone A |
| DE10357452A1 (en) | 2003-12-03 | 2005-06-30 | Beiersdorf Ag | Cosmetic preparations containing licochalcone A or an extract of Radix Glycyrrhizae inflatae, containing licochalcone A, and organic thickener |
| DE10356869A1 (en) | 2003-12-03 | 2005-07-07 | Beiersdorf Ag | Surfactant-containing preparation with licochalcone A |
| DE10357046A1 (en) * | 2003-12-04 | 2005-06-30 | Beiersdorf Ag | Cosmetic or dermatological preparations containing a combination of green dye and anti-inflammatory agent |
| DE102004009149A1 (en) | 2004-02-23 | 2005-09-08 | Beiersdorf Ag | Stable cosmetics |
| DE102004012135A1 (en) * | 2004-03-12 | 2005-09-29 | Beiersdorf Ag | Preparation against reddened skin |
| DE102004027476A1 (en) * | 2004-06-02 | 2005-12-22 | Beiersdorf Ag | 2-phenylehtyl benzoate in oil-in-water cosmetic UV sunscreen emulsions |
| DE102004042299A1 (en) * | 2004-08-27 | 2006-03-23 | Lancaster Group Gmbh | Cosmetic brightening and cleansing agent for skin, comprises complex of plant extract, and conventional cosmetic carriers, additives and other active substances |
| DE102006047154A1 (en) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and an antiinflammatory agent |
| DE102006047153A1 (en) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and an antiinflammatory agent |
| DE102007005093A1 (en) * | 2007-01-25 | 2008-07-31 | Beiersdorf Ag | Cosmetic preparation for the prophylaxis or treatment of skin pigmentation, contains a combination of active ingredients comprising salicylic and-or glycolic acid plus titanium dioxide and-or zinc oxide pigments |
-
2008
- 2008-09-16 DE DE102008048328A patent/DE102008048328A1/en not_active Ceased
-
2009
- 2009-09-11 ES ES09778483T patent/ES2392386T3/en active Active
- 2009-09-11 ES ES11008456T patent/ES2430257T5/en active Active
- 2009-09-11 EP EP09778483A patent/EP2337545B1/en not_active Not-in-force
- 2009-09-11 WO PCT/EP2009/006608 patent/WO2010031522A1/en not_active Ceased
- 2009-09-11 US US13/119,036 patent/US20120136067A1/en not_active Abandoned
- 2009-09-11 EP EP11008456.3A patent/EP2471501B2/en active Active
-
2016
- 2016-11-23 US US15/359,841 patent/US10603256B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562353B1 (en) * | 1998-05-12 | 2003-05-13 | Societe L'oreal S.A. | Desquamation/epidermal renewal of the skin and/or combating skin aging |
| US20100104523A1 (en) * | 2007-01-25 | 2010-04-29 | Ciba Corporation | Stabilization of uv-sensitive active ingredients |
| US20100166687A1 (en) * | 2007-03-01 | 2010-07-01 | Coty Prestige Lancaster Group Gmbh | Cosmetic light protection agent |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170038262A (en) * | 2015-09-30 | 2017-04-07 | (주)아모레퍼시픽 | Oil-in-water type emulsion composition |
| US11077031B2 (en) * | 2015-09-30 | 2021-08-03 | Amorepacific Corporation | Oil-in-water emulsion composition |
| KR102564048B1 (en) * | 2015-09-30 | 2023-08-04 | (주)아모레퍼시픽 | Oil-in-water type emulsion composition |
| WO2020025257A1 (en) | 2018-07-30 | 2020-02-06 | Unilever N.V. | Compositions comprising active botanical ingredients |
| US11291624B2 (en) | 2018-07-30 | 2022-04-05 | Conopco, Inc. | Compositions comprising active botanical ingredients |
| JP2023500806A (en) * | 2019-11-05 | 2023-01-11 | ディーエスエム アイピー アセッツ ビー.ブイ. | Non-sticky sunscreen composition |
| CN116327704A (en) * | 2023-04-03 | 2023-06-27 | 浙江固瓴生物科技有限公司 | A preparation method and application of nano liquid crystal carrier containing licochalcone A |
| CN120732759A (en) * | 2025-07-31 | 2025-10-03 | 广东肤韵生物科技研究有限公司 | High-power sun-screening composition with light and thin skin feel and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010031522A1 (en) | 2010-03-25 |
| EP2471501A1 (en) | 2012-07-04 |
| ES2430257T3 (en) | 2013-11-19 |
| US10603256B2 (en) | 2020-03-31 |
| US20170071832A1 (en) | 2017-03-16 |
| EP2471501B1 (en) | 2013-08-28 |
| ES2392386T3 (en) | 2012-12-10 |
| ES2430257T5 (en) | 2022-04-04 |
| EP2337545A1 (en) | 2011-06-29 |
| EP2471501B2 (en) | 2021-11-17 |
| EP2337545B1 (en) | 2012-08-15 |
| DE102008048328A1 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10603256B2 (en) | Oil/water active ingredient emulsion containing UV filter | |
| AU2020200941B2 (en) | Octocrylene-free sunscreen composition with low stickiness | |
| TWI899374B (en) | Novel solubilizing system for liposoluble organic solar filters | |
| AU2016273839A1 (en) | Sunscreen containing titanium dioxide | |
| ES3023056T3 (en) | Sunscreen compositions comprising butyl methoxydibenzoylmethane, triazine derivatives and photostabilizer | |
| JP6834086B2 (en) | 10-Hydroxystearic acid composition | |
| JP2025169464A (en) | Non-sticky sunscreen composition | |
| CN109069381B (en) | 10-hydroxystearic acid composition | |
| US20110268674A1 (en) | Polyamide-5 compounds in cosmetic preparations | |
| US20210045978A1 (en) | O/w emulsion comprising photochemically stable 4-(tert-butyl)-4-methoxydibenzoylmethane in oil droplets smaller than 8 micrometers | |
| ES2531631T3 (en) | Sun protection compositions | |
| US20230083509A1 (en) | Polyacrylate-free cosmetic preparation | |
| JP2000178266A (en) | Benzylidene-γ-butyrolactone, methods for their preparation and their use as UV absorbers | |
| WO2025257313A1 (en) | Composition comprising a novel uv filter combination | |
| US20250375369A1 (en) | Compositions comprising self tanning agents and certain sphingolipids and/or certain sphingoid bases | |
| WO2025257312A1 (en) | Composition comprising a novel uv filter combination | |
| DE202008018656U1 (en) | UV filter-containing O / W active ingredient emulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BEIERSDORF AG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RUPPERT, STEPHAN;STEIKERT, CLAUDIA;BLOHM, ALEXANDRA;SIGNING DATES FROM 20110413 TO 20110429;REEL/FRAME:026212/0994 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |
